Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case Series.
Journal: Journal of the advanced practitioner in oncology
Published: August 25, 2021
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk.
Journal: Acta haematologica
Published: April 09, 2021
Showing 1-2 of 2
Last Updated: 09/26/2026